Ligandrol LGD-4033 is a selective androgenic receptor modulator (SARM) that was developed by Ligand Pharmaceuticals. It is primarily a mass-building SARM that was originally developed to treat muscle-wasting conditions.

Ligandrol is one of the best SARMs for increasing lean mass and it activates the muscle regeneration process after a workout. This SARM also increases both energy and strength.

Ligandrol can be stacked with a cutting SARM for weight loss in order to preserve muscle size while you are stripping off body fat.

In terms of weight loss, Ligandrol is able to attach to fat receptors and stimulate fat loss. It will boost the metabolism for faster calorie burning.

YK11 is a synthetic steroid categorized as a Selective Androgen Receptor Modulator (SARM), engineered to selectively engage androgen receptors in skeletal muscles and bones, closely emulating the anabolic effects of testosterone with minimized systemic side effects associated with conventional anabolic steroids. This specificity is what renders YK11 particularly intriguing for both therapeutic applications and bodybuilding endeavors.

A primary advantage of YK11 lies in its ability to substantially enhance muscle mass and strength by promoting more efficacious muscle cell growth than endogenous testosterone, facilitating users in achieving fitness objectives more swiftly. Furthermore, YK11 is postulated to positively impact bone health by augmenting bone density, offering potential benefits in the prevention of fractures and osteoporosis.

Distinctively, YK11‘s action mechanism encompasses the inhibition of myostatin, a growth differentiation factor that plays a critical role in regulating muscle mass. Inhibition of myostatin by YK11 could theoretically allow individuals to transcend their genetic limits in muscle development. This characteristic of YK11 is of particular interest to the scientific community and fitness enthusiasts aiming to maximize muscular gains.

Notwithstanding its promising attributes, it is paramount to acknowledge that YK11, akin to all SARMs, is still in the investigational phase, and its comprehensive safety profile remains undetermined. Prospective users should exercise caution, mindful of the potential for adverse effects and the current absence of regulatory endorsement for human application.

Testolone Rad 140 is a selective androgen receptor modulator (SARM) that was created for the purpose of treating breast cancer and muscle wasting in postmenopausal women. It effectively enhances the body’s natural production of testosterone and also increases lean body mass.

Since it attaches selectively to androgen receptors, it does not carry the sort of side effects that come with anabolic steroids.

Testolone primarily increases lean muscle tissue by enhancing testosterone and human growth hormone as well as boosting other anabolic effects following intense weight training. It may also be able to increase training energy, endurance, and speed while working out.

Testolone is considered to be one of the best SARMs for muscle-building effects but it has also been shown to be effective in fat burning as well.

An initial study conducted on monkeys showed that the administration of Testolone increased their body weight by 10 percent after 28 days of use. Another similar study showed that the negative effects on the prostate and seminal vesicles were significantly reduced by taking Testolone along with synthetic testosterone.